(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPTUMRX VIGILANT DRUG PROGRAM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPTUMRX VIGILANT DRUG PROGRAM

ST13

US500000090356194

Class

36

Filing

90356194

Registration

6605642

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

07/30/2025

Trademark type

Word

Nice classes

36

Filing date

12/03/2020

Registration date

01/04/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/04/2022

Last transaction

07/30/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2020-12-00

First use in commerce

2020-12-00

Drawing code

4

Owner type

03

Owner location

Eden Prairie, MN

Examiner

CAYCEDO, CATHERINE

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Optum, Inc.
Optum, Inc.

Representatives

Linhda Nguyen UnitedHealth Group Incorporated

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Insurance administration of prescription drug benefit plans; Administration of pharmacy benefit plans; Prescription drug and pharmacy benefit claims processing services; Pharmacy benefit management services; Organizing and administering preferred provider plans for a network of pharmacy providers; Providing on-line information in the field of pharmacy benefits; Administration of a prescription drug savings program insurance benefit for managing prescription drug costs and utilization trends

Publications

History of USPTO decisions and trademark events.

28 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/23/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/23/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/23/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/23/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/23/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/23/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/17/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/17/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/04/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/19/2021

PUBO

PUBLISHED FOR OPPOSITION

10/19/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/29/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

09/11/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/10/2021

IUAA

USE AMENDMENT ACCEPTED

09/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/03/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/03/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/09/2021

GNRT

NON-FINAL ACTION E-MAILED

04/09/2021

CNRT

NON-FINAL ACTION WRITTEN

04/09/2021

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

04/03/2021

IUAF

USE AMENDMENT FILED

04/03/2021

EAAU

TEAS AMENDMENT OF USE RECEIVED

04/02/2021

DOCK

ASSIGNED TO EXAMINER

03/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/08/2021

NWAP

NEW APPLICATION ENTERED

12/07/2020

Continuous trademark protection

Get notified about every new filing that threatens OPTUMRX VIGILANT DRUG PROGRAM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.